Comtan is an active pharmaceutical ingredient used in the manufacturing of antiparkinson medications. It functions as an enzyme inhibitor, specifically targeting catechol-O-methyltransferase, and is employed as a pharmaceutical raw material in drug production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 116314-67-1
Entacapone
pharmaceutical raw material
(S)-duloxetine
pharmaceutical raw material
(R)-3-amino-1,2,3,4-terahydrocarbazole
pharmaceutical raw material
Mycophenolate mofetil hydrochloride
pharmaceutical raw material
N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate
pharmaceutical raw material
(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
JRURYQJSLYLRLN-BJMVGYQFSA-N
CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N